ArticleJournal of medicinal chemistry2024

Discovery of the Clinical Candidate Sonrotoclax (BGB-11417), a Highly Potent and Selective Inhibitor for Both WT and G101V Mutant Bcl-2.

Yunhang Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.